Telephone provides unique entry into the lives of out-of-reach patients

In 2010, only about 8% of Medicare Part D enrollees who were eligible for a comprehensive medication review (CMR) received one, according to CMS. Cynthia Tudor, PhD, Director of the Medicare Drug Benefit and C and D Data Group, predicted last March at the CMS 2012 Medicare Prescription Drug Benefit Symposium that the number of eligible patients who receive the review will rise as more patients become aware of MTM and its value.